Prognosis Associated with Complete Pathological Response Following Neoadjuvant Treatment for PancreaTic AdenOcarciNOma in the FOFLIRINOX Era: the Multicenter TONO Study.
AuteursAddeo P, Muzzolini M, Laurent C, Heyd B, Sauvanet A, Garnier J, Alfano MS, Gaujoux S, De Ponthaud C, Marchese U, Da Silva D, Buc E, Souche R, Fabre JM, Colombo PE, Ferre L, Foguenne M, Hubert C, El Amrani M, Truant S, Schwartz L, Regenet N, Dupre A, Brustia R, Cherif R, Navez J, Darnis B, Facy O, Grellet R, Piessen G, Veziant J, Rhaiem R, Kianmanesh R, Fernandez-De-Sevilla E, Gelli M, Taibi A, Georges P, Mabrut JY, Lesurtel M, Doussot A, Bachellier P
Factors associated with therapeutic response to adalimumab in hidradenitis suppurativa: evidence from the Belgian patients of the European Registry for Hidradenitis Suppurativa (ERHS-Be).
AuteursDaoud M, Benhadou F, Suppa M, Sarkis AS, Heudens S, Desmarest L, Njimi H, Daxhelet M, Nobile L, Karama J, White JM, Jemec GBE, Del Marmol V
Factors associated with therapeutic response to adalimumab in hidradenitis suppurativa: evidence from the Belgian patients of the European Registry for Hidradenitis Suppurativa (ERHS-Be).
AuteursDaoud M, Benhadou F, Suppa M, Sarkis AS, Heudens S, Desmarest L, Njimi H, Daxhelet M, Nobile L, Karama J, White JM, Jemec GBE, Del Marmol V
Factors associated with therapeutic response to adalimumab in hidradenitis suppurativa: evidence from the Belgian patients of the European Registry for Hidradenitis Suppurativa (ERHS-Be).
AuteursDaoud M, Benhadou F, Suppa M, Sarkis AS, Heudens S, Desmarest L, Njimi H, Daxhelet M, Nobile L, Karama J, White JM, Jemec GBE, Del Marmol V
Factors associated with therapeutic response to adalimumab in hidradenitis suppurativa: evidence from the Belgian patients of the European Registry for Hidradenitis Suppurativa (ERHS-Be).
AuteursDaoud M, Benhadou F, Suppa M, Sarkis AS, Heudens S, Desmarest L, Njimi H, Daxhelet M, Nobile L, Karama J, White JM, Jemec GBE, Del Marmol V
